A*Star
Initial findings from the country's 10-year National Precision Medicine program could yield genetic tests tailored to Asian populations within Singapore and abroad.
Singapore Institutions Launch Program to Diagnose, Treat EBV-Associated Nasopharyngeal Cancer
The program, funded by Singapore's National Research Foundation, aims to identify Epstein-Barr virus strains associated with NPC in Southeast Asian populations.
Avatamed, A*STAR Launch Joint Precision Oncology Lab in Singapore
Together with Singapore's Agency for Science, Technology, and Research, Avatamed will offer its drug screening platform to oncologists and drugmakers.
The assay underwent clinical validation at three centers in Singapore and 5,248 patients were ultimately screened using the test.
Singapore's Avatamed Raises $1M in Seed Funding
Avatamed will use the funds to expand into the Asia-Pacific market and set up a lab in Singapore to provide precision cancer drug screening services.